Cardio Care Live

CME Speakers

NLA Session Highlights

  • Peter H. Jones, MD, FACP, FNLA

    Peter H. Jones, MD, FACP, FNLA

    Peter H. Jones, MD, FACP, FNLA

    Associate Professor of Medicine

    Peter Howard Jones, MD, FACP, FNLA, is an associate professor in the Department of Medicine, Center for Cardiovascular Disease Prevention at the Baylor College of Medicine in Houston, Texas. He also serves as co-director of the Lipid Metabolism and Atherosclerosis Clinic, and is the medical director for the Weight Management Center at the Houston Methodist Hospital. Dr Jones has served on numerous academic, scientific and community committees, and has published more than 200 clinical abstracts, articles, and chapters in textbooks. He is the chief science officer for the National Lipid Association and an associate editor of the Journal of Clinical Lipidology. Dr Jones received his medical degree from Baylor College of Medicine, where he also completed his internal medicine residency.
  • Christie M. Ballantyne, MD, FNLA

    Christie M. Ballantyne, MD, FNLA

    Christie M. Ballantyne, MD, FNLA

    Professor of Medicine

    Christie Ballantyne, MD, is director for the Center for Cardiovascular Disease Prevention at the Houston Methodist DeBakey Heart & Vascular Center in Texas, as well as vice chair of research for the Department of Medicine, chief of cardiology, and chief of cardiovascular research at Baylor College of Medicine. He is an investigator for the American Heart Association and he receives funding from the National Institutes of Health in basic research of leukocyte-endothelial interactions, translations research in biomarkers and clinical trials. Dr Ballantyne has over 600 publications in the area of atherosclerosis, lipids and inflammation, is an editorial director for www.lipidsonline.org, and is on the editorial board for Circulation. He received is MD from Baylor College of Medicine.

PCSK9 Inhibitors and CV Risk Reduction

  • Michael J. Blaha, MD, MPH

    Michael J. Blaha, MD, MPH

    Michael J. Blaha, MD, MPH

    Director of Clinical Research, Ciccarone Center for the Prevention of Heart Disease; Assistant Professor of Medicine

    Michael J. Blaha, MD, MPH, is director of clinical research for the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease in Baltimore, Maryland, and assistant professor of medicine at the Johns Hopkins Bloomberg School of Public Health. A practicing preventive noninvasive cardiologist, his work includes improving cardiovascular risk prediction through novel methods of early detection of atherosclerosis, including the use of cardiac computed tomography Dr Blaha is an associate editor for the journal Atherosclerosis, has published over 250 original papers, and two books on the metabolic syndrome. He is a founding member of The FIT Project, a principal investigator of the Coronary Artery Calcium Consortium, and co-director of the mobile health mActive Program at Johns Hopkins.
  • Michael Miller, MD, FACC, FAHA

    Michael Miller, MD, FACC, FAHA

    Michael Miller, MD, FACC, FAHA

    Professor of Cardiovascular Medicine, Epidemiology & Public Health

    Michael Miller, MD, FACC, FAHA, is professor of medicine at the University of Maryland School of Medicine in Baltimore and director of the Center for Preventive Cardiology for the University of Maryland Medical System. Dr Miller’s main research interests are disorders of lipid and lipoprotein metabolism; molecular studies of HDL cholesterol, triglycerides, and the postprandial response to dietary fat; nontraditional coronary risk factors; and clinical trials to reduce atherosclerosis. He serves on the Leadership Council of the American Heart Association (AHA), is a member of the AHA Nutrition and Lifestyle Committee, is past president of the American Society of Preventive Cardiology, and has published more than 250 scientific papers in leading medical journals such as JACC and JAMA.
  • James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA, FASPC

    James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA, FASPC

    James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA, FASPC

    Lipidology & Cardiovascular Disease Prevention, Clinical Assistant Professor of Medicine

    James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA, FASPC, is a clinical assistant professor of medicine at NYU School of Medicine and the NYU Center for Prevention of Cardiovascular Disease, and director of the Bellevue Hospital Lipid Clinic. Dr Underberg holds joint appointments in the Divisions of General Internal Medicine and Endocrinology at NYU. His clinical interests focus on the management of patients with lipids and lipoprotein disorders, and cardiovascular disease prevention. He maintains an active clinical research program in these areas, and has authored numerous articles and book chapters in the field of clinical lipidology. He is a diplomate of the American Board of Clinical Lipidology, and president-elect, board member and fellow of the National Lipid Association.
  • Marc S. Sabatine, MD, MPH

    Marc S. Sabatine, MD, MPH

    Marc S. Sabatine, MD, MPH

    Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine

    Marc S. Sabatine, MD, MPH, is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group, the Lewis Dexter, MD, Distinguished Chair in Cardiovascular Medicine at Brigham and Women’s Hospital, and a professor of medicine at Harvard Medical School in Boston, Massachusetts. As chairman of the TIMI Study Group, Dr Sabatine leads an academic research organization whose mission is to advance the knowledge and care of patients suffering from cardiovascular disease and its risk factors. He has led several large-scale, international, randomized controlled trials of novel antithrombotic, lipid-lowering and other pharmacotherapies, has a long-standing interest in pharmacogenetics, and has made seminal observations on the ability to use genetics for personalized medicine.

Pulmonary Arterial Hypertension

  • Victor F. Tapson, MD, FCCP, FRCP

    Victor F. Tapson, MD, FCCP, FRCP

    Victor F. Tapson, MD, FCCP, FRCP

    Professor of Medicine, Pulmonary Critical Care Medicine

    Victor F. Tapson, MD, FCCP, FRCP, is professor of medicine, director of the Clinical Research for the Women’s Guild Lung Institute and the Venous Thromboembolism and Pulmonary Vascular Disease Research Program, and associate director of the Pulmonary and Critical Care Division at Cedars-Sinai Medical Center in Los Angeles, California. Dr Tapson has devoted his career to patient care, research, and teaching in pulmonary hypertension and pulmonary embolism. He’s served on the steering committees for the World PH Guidelines, started the first PAH journal, Advances in PH, and served as worldwide PI or co-PI for several venous thromboembolism registries. He is currently PI for the OPTALYSE PE, BiO2 IVCF and FLARE clot-extraction studies, and the TAFIa clinical trial in acute PE.

Heart Failure

  • Akshay S. Desai, MD, MPH

    Akshay S. Desai, MD, MPH

    Akshay S. Desai, MD, MPH

    Director, Cardiomyopathy and Heart Failure Program

    Akshay Desai, MD, MPH, is the director of the Cardiomyopathy & Heart Failure Program in the Advanced Heart Disease Section of the Cardiovascular Division, Brigham and Women’s Hospital, and an associate professor of medicine at Harvard Medical School, both in Boston, Massachusetts. He divides his time between treating patients with advanced heart disease and clinical research in cardiovascular clinical trials, with emphasis on pathophysiology, pharmacologic treatment, and ambulatory management of patients with heart failure. He earned his MD from Harvard Medical School, completed an internal medicine internship and residency, as well as cardiovascular medicine and advanced heart failure fellowships, at Brigham and Women’s Hospital. He holds an MPH from the Harvard School of Public Health.
  • James L. Januzzi, Jr., MD, FACC, FESC

    James L. Januzzi, Jr., MD, FACC, FESC

    James L. Januzzi, Jr., MD, FACC, FESC

    Physician, Cardiology Division

    James L. Januzzi, MD, is the Hutter Family Professor of Medicine at Harvard Medical School, a staff cardiologist at Massachusetts General Hospital, and senior cardiometabolic faculty at Baim Institute for Clinical Research in Boston. His research has contributed to the understanding of cardiac biomarker testing, where his studies have set international standards for use in diagnosis, prognosis, and management of patients suffering from acutely decompensated heart failure, chronic heart failure as well as those with acute coronary syndromes. Dr Januzzi has published hundreds of manuscripts, book chapters and review articles, has edited two textbooks on cardiac biomarker testing, and is on the editorial board of numerous scientific journals. He earned his MD from New York Medical College.

All Speakers

  • Peter H. Jones, MD, FACP, FNLA

    Peter H. Jones, MD, FACP, FNLA

    Peter H. Jones, MD, FACP, FNLA

    Associate Professor of Medicine

    Peter Howard Jones, MD, FACP, FNLA, is an associate professor in the Department of Medicine, Center for Cardiovascular Disease Prevention at the Baylor College of Medicine in Houston, Texas. He also serves as co-director of the Lipid Metabolism and Atherosclerosis Clinic, and is the medical director for the Weight Management Center at the Houston Methodist Hospital. Dr Jones has served on numerous academic, scientific and community committees, and has published more than 200 clinical abstracts, articles, and chapters in textbooks. He is the chief science officer for the National Lipid Association and an associate editor of the Journal of Clinical Lipidology. Dr Jones received his medical degree from Baylor College of Medicine, where he also completed his internal medicine residency.
  • Christie M. Ballantyne, MD, FNLA

    Christie M. Ballantyne, MD, FNLA

    Christie M. Ballantyne, MD, FNLA

    Professor of Medicine

    Christie Ballantyne, MD, is director for the Center for Cardiovascular Disease Prevention at the Houston Methodist DeBakey Heart & Vascular Center in Texas, as well as vice chair of research for the Department of Medicine, chief of cardiology, and chief of cardiovascular research at Baylor College of Medicine. He is an investigator for the American Heart Association and he receives funding from the National Institutes of Health in basic research of leukocyte-endothelial interactions, translations research in biomarkers and clinical trials. Dr Ballantyne has over 600 publications in the area of atherosclerosis, lipids and inflammation, is an editorial director for www.lipidsonline.org, and is on the editorial board for Circulation. He received is MD from Baylor College of Medicine.
  • Michael J. Blaha, MD, MPH

    Michael J. Blaha, MD, MPH

    Michael J. Blaha, MD, MPH

    Director of Clinical Research, Ciccarone Center for the Prevention of Heart Disease; Assistant Professor of Medicine

    Michael J. Blaha, MD, MPH, is director of clinical research for the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease in Baltimore, Maryland, and assistant professor of medicine at the Johns Hopkins Bloomberg School of Public Health. A practicing preventive noninvasive cardiologist, his work includes improving cardiovascular risk prediction through novel methods of early detection of atherosclerosis, including the use of cardiac computed tomography Dr Blaha is an associate editor for the journal Atherosclerosis, has published over 250 original papers, and two books on the metabolic syndrome. He is a founding member of The FIT Project, a principal investigator of the Coronary Artery Calcium Consortium, and co-director of the mobile health mActive Program at Johns Hopkins.
  • Michael Miller, MD, FACC, FAHA

    Michael Miller, MD, FACC, FAHA

    Michael Miller, MD, FACC, FAHA

    Professor of Cardiovascular Medicine, Epidemiology & Public Health

    Michael Miller, MD, FACC, FAHA, is professor of medicine at the University of Maryland School of Medicine in Baltimore and director of the Center for Preventive Cardiology for the University of Maryland Medical System. Dr Miller’s main research interests are disorders of lipid and lipoprotein metabolism; molecular studies of HDL cholesterol, triglycerides, and the postprandial response to dietary fat; nontraditional coronary risk factors; and clinical trials to reduce atherosclerosis. He serves on the Leadership Council of the American Heart Association (AHA), is a member of the AHA Nutrition and Lifestyle Committee, is past president of the American Society of Preventive Cardiology, and has published more than 250 scientific papers in leading medical journals such as JACC and JAMA.
  • James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA, FASPC

    James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA, FASPC

    James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA, FASPC

    Lipidology & Cardiovascular Disease Prevention, Clinical Assistant Professor of Medicine

    James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA, FASPC, is a clinical assistant professor of medicine at NYU School of Medicine and the NYU Center for Prevention of Cardiovascular Disease, and director of the Bellevue Hospital Lipid Clinic. Dr Underberg holds joint appointments in the Divisions of General Internal Medicine and Endocrinology at NYU. His clinical interests focus on the management of patients with lipids and lipoprotein disorders, and cardiovascular disease prevention. He maintains an active clinical research program in these areas, and has authored numerous articles and book chapters in the field of clinical lipidology. He is a diplomate of the American Board of Clinical Lipidology, and president-elect, board member and fellow of the National Lipid Association.
  • Marc S. Sabatine, MD, MPH

    Marc S. Sabatine, MD, MPH

    Marc S. Sabatine, MD, MPH

    Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine

    Marc S. Sabatine, MD, MPH, is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group, the Lewis Dexter, MD, Distinguished Chair in Cardiovascular Medicine at Brigham and Women’s Hospital, and a professor of medicine at Harvard Medical School in Boston, Massachusetts. As chairman of the TIMI Study Group, Dr Sabatine leads an academic research organization whose mission is to advance the knowledge and care of patients suffering from cardiovascular disease and its risk factors. He has led several large-scale, international, randomized controlled trials of novel antithrombotic, lipid-lowering and other pharmacotherapies, has a long-standing interest in pharmacogenetics, and has made seminal observations on the ability to use genetics for personalized medicine.
  • Victor F. Tapson, MD, FCCP, FRCP

    Victor F. Tapson, MD, FCCP, FRCP

    Victor F. Tapson, MD, FCCP, FRCP

    Professor of Medicine, Pulmonary Critical Care Medicine

    Victor F. Tapson, MD, FCCP, FRCP, is professor of medicine, director of the Clinical Research for the Women’s Guild Lung Institute and the Venous Thromboembolism and Pulmonary Vascular Disease Research Program, and associate director of the Pulmonary and Critical Care Division at Cedars-Sinai Medical Center in Los Angeles, California. Dr Tapson has devoted his career to patient care, research, and teaching in pulmonary hypertension and pulmonary embolism. He’s served on the steering committees for the World PH Guidelines, started the first PAH journal, Advances in PH, and served as worldwide PI or co-PI for several venous thromboembolism registries. He is currently PI for the OPTALYSE PE, BiO2 IVCF and FLARE clot-extraction studies, and the TAFIa clinical trial in acute PE.
  • Akshay S. Desai, MD, MPH

    Akshay S. Desai, MD, MPH

    Akshay S. Desai, MD, MPH

    Director, Cardiomyopathy and Heart Failure Program

    Akshay Desai, MD, MPH, is the director of the Cardiomyopathy & Heart Failure Program in the Advanced Heart Disease Section of the Cardiovascular Division, Brigham and Women’s Hospital, and an associate professor of medicine at Harvard Medical School, both in Boston, Massachusetts. He divides his time between treating patients with advanced heart disease and clinical research in cardiovascular clinical trials, with emphasis on pathophysiology, pharmacologic treatment, and ambulatory management of patients with heart failure. He earned his MD from Harvard Medical School, completed an internal medicine internship and residency, as well as cardiovascular medicine and advanced heart failure fellowships, at Brigham and Women’s Hospital. He holds an MPH from the Harvard School of Public Health.
  • James L. Januzzi, Jr., MD, FACC, FESC

    James L. Januzzi, Jr., MD, FACC, FESC

    James L. Januzzi, Jr., MD, FACC, FESC

    Physician, Cardiology Division

    James L. Januzzi, MD, is the Hutter Family Professor of Medicine at Harvard Medical School, a staff cardiologist at Massachusetts General Hospital, and senior cardiometabolic faculty at Baim Institute for Clinical Research in Boston. His research has contributed to the understanding of cardiac biomarker testing, where his studies have set international standards for use in diagnosis, prognosis, and management of patients suffering from acutely decompensated heart failure, chronic heart failure as well as those with acute coronary syndromes. Dr Januzzi has published hundreds of manuscripts, book chapters and review articles, has edited two textbooks on cardiac biomarker testing, and is on the editorial board of numerous scientific journals. He earned his MD from New York Medical College.